| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-18859-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-99421-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-11924-25ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-12776-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-2660-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-50606-0.025ml | |||
![Flow Cytometry: TWEAK/TNFSF12 Antibody (CARL-1) [NBP3-09144] - Separation of CD255 transfected L5178Y cells (red-filled) from nontransfected L5178Y cells (black-dashed) in flow cytometry analysis (surface staining) stained using anti-human CD255 (CARL-1) purified antibody (concentration in sample 9 ug/ml) GAM APC.](http://images.novusbio.com/fullsize/TWEAK-TNFSF12-Antibody-CARL-1-Flow-Cytometry-NBP3-09144-img0001.jpg "Flow Cytometry: TWEAK/TNFSF12 Antibody (CARL-1) [NBP3-09144] - Separation of CD255 transfected L5178Y cells (red-filled) from nontransfected L5178Y cells (black-dashed) in flow cytometry analysis (surface staining) stained using anti-human CD255 (CARL-1) purified antibody (concentration in sample 9 ug/ml) GAM APC.")
![Western Blot: RbAp46 Antibody [NBP2-86767] - WB Suggested Anti-RBBP7 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:62500. Positive Control: HepG2 cell lysate](http://images.novusbio.com/fullsize/RbAp46-Antibody-Western-Blot-NBP2-86767-img0001.jpg "Western Blot: RbAp46 Antibody [NBP2-86767] - WB Suggested Anti-RBBP7 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:62500. Positive Control: HepG2 cell lysate")
![Western Blot: A-Myb Antibody [NBP2-86996] - WB Suggested Anti-MYBL1 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:62500. Positive Control: Hela cell lysate](http://images.novusbio.com/fullsize/A-Myb-Antibody-Western-Blot-NBP2-86996-img0001.jpg "Western Blot: A-Myb Antibody [NBP2-86996] - WB Suggested Anti-MYBL1 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:62500. Positive Control: Hela cell lysate")
![Western Blot: NF2/Merlin Antibody [NBP2-99421] - Anti-NF2/Merlin rabbit polyclonal antibody at 1:500 dilution. Lane A: HeLa Whole Cell Lysate. Lysates/proteins at 30 ug per lane. Secondary Goat Anti-Rabbit IgG (H+L)/HRP at 1/10000 dilution. Developed using the ECL technique. Performed under reducing conditions. Predicted band size: 69 kDa. Observed band size: 69 kDa (We are unsure as to the identity of these extra bands).](http://images.novusbio.com/fullsize/NF2-Merlin-Antibody-Western-Blot-NBP2-99421-img0002.jpg "Western Blot: NF2/Merlin Antibody [NBP2-99421] - Anti-NF2/Merlin rabbit polyclonal antibody at 1:500 dilution. Lane A: HeLa Whole Cell Lysate. Lysates/proteins at 30 ug per lane. Secondary Goat Anti-Rabbit IgG (H+L)/HRP at 1/10000 dilution. Developed using the ECL technique. Performed under reducing conditions. Predicted band size: 69 kDa. Observed band size: 69 kDa (We are unsure as to the identity of these extra bands).")
![Western Blot: p130 Antibody [NBP3-12776] - Lane A: Jurkat Whole Cell LysateLysates/proteins at 30 ug per lane.SecondaryGoat Anti-Rabbit IgG H&L (Dylight800) at 1/10000 dilution.Developed using the Odyssey technique. Performed under reducing conditions.Predicted band size:128 kDaObserved band size:128 kDa(We are unsure as to the identity of these extra bands.)](http://images.novusbio.com/fullsize/p130-Antibody-Western-Blot-NBP3-12776-img0001.jpg "Western Blot: p130 Antibody [NBP3-12776] - Lane A: Jurkat Whole Cell LysateLysates/proteins at 30 ug per lane.SecondaryGoat Anti-Rabbit IgG H&L (Dylight800) at 1/10000 dilution.Developed using the Odyssey technique. Performed under reducing conditions.Predicted band size:128 kDaObserved band size:128 kDa(We are unsure as to the identity of these extra bands.)")
![Immunohistochemistry-Paraffin: RUNX1/CBFA2 Antibody [NBP3-14463] - Human Breast: Formalin-Fixed, Paraffin-Embedded (FFPE)](http://images.novusbio.com/fullsize/RUNX1-CBFA2 Antibody-Immunohistochemistry-Paraffin-NBP3-14463-img0001.jpg "Immunohistochemistry-Paraffin: RUNX1/CBFA2 Antibody [NBP3-14463] - Human Breast: Formalin-Fixed, Paraffin-Embedded (FFPE)")
![Western Blot: RBBP4/RbAp48 Antibody (C.15200033) [NBP2-62798] - Analysis of nuclear extracts from HeLa cells (20 ug) using the monoclonal antibody against hRbAp46/48.](http://images.novusbio.com/fullsize/RBBP4-RbAp48-Antibody-C-15200033-Western-Blot-NBP2-62798-img0001.jpg "Western Blot: RBBP4/RbAp48 Antibody (C.15200033) [NBP2-62798] - Analysis of nuclear extracts from HeLa cells (20 ug) using the monoclonal antibody against hRbAp46/48.")
![Chromatin Immunoprecipitation: KAT3B/p300 Antibody (1H11G2) [NBP2-59233] - ChIP was performed using HeLa cells, the antibody against p300 and optimized PCR primer sets for qPCR. ChIP was performed with a ChIP-seq kit, using sheared chromatin from 4 million cells. A titration of the antibody consisting of 1, 2, 5 and 10 ug per ChIP experiment was analysed. IgG (2 ug/IP) was used as negative IP control. Quantitative PCR was performed with primers for two genomic regions near the ANKRD32 and IRS2 genes, used as positive controls, and for the coding region of the inactive MYOD1 gene and an intergeic region on chromosome 11, used as negative controls. Figure shows the recovery, expressed as a % of input (the relative amount of immunoprecipitated DNA compared to input DNA after qPCR analysis).](http://images.novusbio.com/fullsize/KAT3B-p300-Antibody-1H11G2-Chromatin-Immunoprecipitation-NBP2-59233-img0001.jpg "Chromatin Immunoprecipitation: KAT3B/p300 Antibody (1H11G2) [NBP2-59233] - ChIP was performed using HeLa cells, the antibody against p300 and optimized PCR primer sets for qPCR. ChIP was performed with a ChIP-seq kit, using sheared chromatin from 4 million cells. A titration of the antibody consisting of 1, 2, 5 and 10 ug per ChIP experiment was analysed. IgG (2 ug/IP) was used as negative IP control. Quantitative PCR was performed with primers for two genomic regions near the ANKRD32 and IRS2 genes, used as positive controls, and for the coding region of the inactive MYOD1 gene and an intergeic region on chromosome 11, used as negative controls. Figure shows the recovery, expressed as a % of input (the relative amount of immunoprecipitated DNA compared to input DNA after qPCR analysis).")
![Western Blot: AIF Antibody (3C11) [NBP2-50606] - Western blot was performed on transfected 293T cell lysates using anti-AIF [3C11].](http://images.novusbio.com/fullsize/AIF-Antibody-3C11-Western-Blot-NBP2-50606-img0001.jpg "Western Blot: AIF Antibody (3C11) [NBP2-50606] - Western blot was performed on transfected 293T cell lysates using anti-AIF [3C11].")